The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UK


BACKGROUND Evaluating long-term prognosis is important for physicians, patients and payers. This study reports the results of a model developed to predict long-term survival for UK patients receiving second-line ipilimumab. METHODS MDX010-20 trial data were used to predict survival for ipilimumab versus UK best supportive care. Two aspects of this… (More)
DOI: 10.1371/journal.pone.0145524


4 Figures and Tables